Conference abstractPublished 22 Jun 2020
Comparative evaluation of therapeutic efficacy and safety of dermabrasion with PGE2 analogue (Dinoprostone), 5-Flourouracil cream (5%) and Tacrolimus(0.1%) cream in localised stable vitiligo
PHD, in field of vitiligo
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Introduction: Vitiligo is associated with huge social stigma in Asain skin. The desire of novel molecules has been since long in the management of vitiligo. Our aim in the study was to evaluate therapeutic efficacy and safety of dermabrasion with PGE2 analogue (Dinoprostone gel), 5-Flourouracil (5%) cream and Tacrolimus 0.1% cream in localised stable vitiligo Methodology & Theoretical Orientation: 60 patients of localised stable vitiligo were taken which were randomly divided into 3 groups. Dermabrasion with Dinoprostone gel, 5-Flourouracil and Tacrolimus 0.1% ointment was done in group 1, 2, and 3 respectively. The respective topical agents were instructed to be applied twice daily till 12 weeks. Follow up was done by VASI, DLQI and photographically four weekly till 36 weeks. Findings: Repigmentation started within 4 weeks in all 3 groups. Excellent response (>75% repigmentation ) was seen in 43%,40% and 54% of group1,2 and 3 patients respectively. Good response(>50% respigmenatation) was observed in 34%,26%, 33%, of patients of group1,2 and 3 respectively. 25-50% repigmentation was seen in 4%,8%,10% in group1,2 and 3 aptients respectively. No significant side effects or reoccurence were found in the study period. Conclusions and significance: Dermabrasion when combined with Dinoprostone gel, 5-Flourouracil (5%), or tacrolimus 0.1% ointment showed similar efficacy and side effect profile in all 3 groups with slight better response with tacrolimus ointment. This study adds novel molecule dinoprostone to the already existing basket for vitiligo mangement.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- BylineArticles whose byline prints “Jaskirat Kaur”